Education
About Us
Working with TipRanks
Follow Us
Agilent (A)
NYSE:A
A Stock Chart & Stats
Day’s Range― - ―
52-Week Range$96.43 - $153.84
Previous CloseN/A
Volume231.77K
Average Volume (3M)1.56M
Market Cap
$34.94B
Enterprise Value$34.59B
Total Cash (Recent Filing)$1.53B
Total Debt (Recent Filing)$3.41B
Price to Earnings (P/E)28.9
Beta1.01
Next Earnings
Dec 01, 2025EPS Estimate
1.58Last Dividend Ex-Date
Jul 01, 2025Dividend Yield0.78%
Share Statistics
EPS (TTM)1.37
Shares Outstanding283,500,430
10 Day Avg. Volume1,904,131
30 Day Avg. Volume1,560,211
Financial Highlights & Ratios
PEG Ratio4.64
Price to Book (P/B)5.29
Price to Sales (P/S)4.79
P/FCF Ratio22.73
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue5.10
Enterprise Value/Gross Profit9.62
Enterprise Value/Ebitda19.25
Forecast
1Y Price Target
$140.80Price Target Upside12.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
Bulls Say, Bears Say
Bulls Say
EarningsAgilent delivered a strong top-line beat-and-raise in FY3Q25, indicating robust performance in its core business.
Market PositionPharma growth remains strong, and Agilent has a differentiated position in a market entering a replacement cycle.
Bears Say
DemandA steep drop-off in U.S. demand for PFAS testing led to a significant decline in the Forensics & Environment segment.
MarginsA weaker margin print and the need for a margin step-up may raise questions about management's guidance conservatism.
TariffsThe company's operating margin was pressured by tariffs, which negatively impacted financial performance.
Agilent News
A FAQ
What was Agilent’s price range in the past 12 months?
Agilent lowest stock price was $96.43 and its highest was $153.84 in the past 12 months.
What is Agilent’s market cap?
Agilent’s market cap is $34.94B.
When is Agilent’s upcoming earnings report date?
Agilent’s upcoming earnings report date is Dec 01, 2025 which is in 75 days.
How were Agilent’s earnings last quarter?
Agilent released its earnings results on Aug 27, 2025. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.368 by $0.002.
Is Agilent overvalued?
According to Wall Street analysts Agilent’s price is currently Undervalued.
Does Agilent pay dividends?
Agilent pays a Quarterly dividend of $0.248 which represents an annual dividend yield of 0.78%. See more information on Agilent dividends here
What is Agilent’s EPS estimate?
Agilent’s EPS estimate is 1.58.
How many shares outstanding does Agilent have?
Agilent has 283,500,430 shares outstanding.
What happened to Agilent’s price movement after its last earnings report?
Agilent reported an EPS of $1.37 in its last earnings report, beating expectations of $1.368. Following the earnings report the stock price went up 5.283%.
Which hedge fund is a major shareholder of Agilent?
Currently, no hedge funds are holding shares in A
Agilent Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$140.80 (12.08% Upside)
$140.80 (12.08% Upside)
Blogger Sentiment
Bullish
A Sentiment 80%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 59.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $815.7 over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 0.5%
Last 30 Days ▲ 0.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.94%
12-Months-Change
Fundamentals
Return on Equity
19.88%
Trailing 12-Months
Asset Growth
11.19%
Trailing 12-Months
Company Description
Agilent
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
A Company Deck
A Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a strong performance with revenue and growth exceeding expectations, driven by significant gains in key markets and regions. However, pressures from tariffs and margin challenges, along with specific market declines, balanced the positive aspects.View all A earnings summariesA Revenue Breakdown
49.39% Life Sciences and Applied Markets
25.36% Diagnostics and genomics
25.25% Agilent CrossLab
A Stock 12 Month Forecast
Average Price Target
$140.80
▲(12.08% Upside)
Technical Analysis
Ownership Overview
0.26% Insiders
27.26% Mutual Funds
21.69% Other Institutional Investors
24.87% Public Companies and Individual Investors